Avid Bioservices, Inc.

Avid Bioservices, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Avid Bioservices, Inc. is a perfect momentum stock. Avid Bioservices, Inc. is not very popular among insiders. Avid Bioservices, Inc. is a mediocre stock to choose.
Log in to see more information.
Avid Bioservices, Inc. engages in the commercial manufacturing focused on biopharmaceutical products...
CDMO Fundamental Data by TradingView

News

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

Globe Newswire TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...\n more…

Avid Bioservices (NASDAQ:CDMO) PT Raised to $12.00
Avid Bioservices (NASDAQ:CDMO) PT Raised to $12.00

Ticker Report Avid Bioservices (NASDAQ:CDMO - Get Free Report) had its price objective upped by stock analysts at Royal Bank of Canada from $8.00 to $12.00 in a research report issued on Tuesday, Benzinga reports...\n more…

William Blair Reaffirms Market Perform Rating for Avid Bioservices (NASDAQ:CDMO)
William Blair Reaffirms Market Perform Rating for Avid Bioservices (NASDAQ:CDMO)

Zolmax Avid Bioservices (NASDAQ:CDMO - Get Free Report)s stock had its "market perform" rating restated by stock analysts at William Blair in a note issued to investors on Tuesday, MarketBeat Ratings...\n more…

Avid Bioservices (NASDAQ:CDMO) Stock Rating Upgraded by StockNews.com
Avid Bioservices (NASDAQ:CDMO) Stock Rating Upgraded by StockNews.com

Ticker Report Avid Bioservices (NASDAQ:CDMO - Get Free Report) was upgraded by stock analysts at StockNews.com to a "sell" rating in a report released on Tuesday. Other research analysts have also issued reports...\n more…

Avid Bioservices (NASDAQ:CDMO) Stock Rating Reaffirmed by William Blair
Avid Bioservices (NASDAQ:CDMO) Stock Rating Reaffirmed by William Blair

Ticker Report Avid Bioservices (NASDAQ:CDMO - Get Free Report)s stock had its "market perform" rating reissued by stock analysts at William Blair in a report released on Tuesday, MarketBeat Ratings reports...\n more…

Avid Bioservices (NASDAQ:CDMO) Shares Gap Up After Analyst Upgrade
Avid Bioservices (NASDAQ:CDMO) Shares Gap Up After Analyst Upgrade

Ticker Report Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) shares gapped up prior to trading on Tuesday after StockNews.com upgraded the stock to a sell rating. The stock had previously closed at $8.95...\n more…